Increasing Availability Of Advanced Clotting Facto..

新しい記事を作成しました

10 の

Increasing Availability Of Advanced Clotting Factor Therapies Is Driving Growth In The Hemophilia B Market | #hemophilia B

Increasing Availability Of Advanced Clotting Factor Therapies Is Driving Growth In The Hemophilia B Market

Increasing Availability Of Advanced Clotting Factor Therapies Is Driving Growth In The Hemophilia B Market

Hemophilia B is a rare inherited bleeding disorder caused by a deficiency or dysfunction of clotting factor IX, leading to prolonged bleeding episodes, spontaneous hemorrhages, and joint damage.

お気に入り

コメント

シェア